{
    "Trade/Device Name(s)": [
        "Randox Immunoassay Speciality Control (II) Levels 1, 2 and 3",
        "Immunoassay Speciality Control (II) Levels 1, 2 and 3"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K121603",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981532"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJY",
        "JY"
    ],
    "Summary Letter Date": "November 20, 2012",
    "Summary Letter Received Date": "October 15, 2012",
    "Submission Date": "October 11, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Calcitonin",
        "Gastrin",
        "Procalcitonin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Vial"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Immunoassay Speciality Control (II) Levels 1, 2 and 3 used as assayed quality control material for Calcitonin, Gastrin, and Procalcitonin",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as assayed quality control material for Calcitonin, Gastrin, and Procalcitonin to monitor the precision of laboratory testing systems",
    "fda_folder": "Clinical Chemistry"
}